Di Cai

Dr. Di Cai is a Partner & Research Analyst at Sanders Capital LLC.
Prior to joining Sanders Capital in 2013, Dr. Cai was a Summer Associate with Kleiner Perkins (2012) where she was part of the China team focused on healthcare investment.
She subsequently worked as a Summer Associate with The Carlyle Group in their Asia Growth Equity Team in Beijing (2012).
From 2009-2011, Dr. Cai worked as a Senior Scientist and Lab Manager at The Scripps Research Institute where she led a team to investigate personalized medicine in lung cancer treatment.
From 2005-2009, Dr. Cai was a Research Scientist at the University of Texas Southwestern Medical Center where she discovered a novel biomarker for lung cancer prognosis.
Prior to her scientific career, Dr. Cai was a presenter on the Tianjin TV Network, the fourth largest TV Network in China, co-hosting a bilingual talk show to promote English learning and cultural exchange.
She received her MBA from The Wharton School of the University of Pennsylvania and a doctorate degree from The University of Texas Southwestern Medical Center.